Table 1.
Baseline characteristics of hematological parameters of the EEC patients and controls
| Hematological Parameters | EEC (n=219), M (Q) | Control (n=219), M (Q) | P-value |
|---|---|---|---|
| Age (Year) | 63 (10) | 62 (12) | .573 |
| Gender (male, N%) | 140 (63.9%) | 140 (63.9%) | 1.000 |
| WBC (×109/L) | 5.43 (1.87) | 5.39 (2.11) | .209 |
| MO (×109/L) | 0.43 (0.16) | 0.33 (0.15) | <.0001* |
| LY (×109/L) | 1.55 (0.61) | 1.75 (0.68) | <.0001* |
| NE (×109/L) | 3.14 (1.51) | 3.10 (1.45) | .282 |
| PLT (×109/L) | 186 (72) | 191 (68) | .050* |
| NLR | 1.86 (1.20) | 1.79 (0.79) | .251 |
| PLR | 112.39 (43.84) | 110.77 (46.53) | .934 |
| MLR | 0.27 (0.12) | 0.19 (0.07) | <.0001* |
| EO (×109/L) | 0.12 (0.12) | 0.12 (0.10) | .679 |
| BA (×109/L) | 0.02 (0.03) | 0.02 (0.02) | .857 |
| RBC (×1012/L) | 4.49 (0.64) | 4.56 (0.62) | .003* |
| HGB (g/L) | 137.00 (19.30) | 139.00 (20.00) | .094 |
| HCT (%) | 40.50 (6.30) | 40.80 (7.50) | .280 |
| MCV (fL) | 91.70 (5.10) | 90.00 (5.30) | .018* |
| MCH (pg) | 30.70 (1.70) | 30.40 (1.90) | .010* |
| MCHC (g/L) | 335.00 (12.00) | 334.00 (11.00) | .475 |
| RDWCV (%) | 12.80 (1.10) | 12.90 (1.00) | .934 |
| PCT (%) | 0.20 (0.07) | 0.21 (0.07) | .248 |
| MPV (fL) | 11.20 (1.72) | 10.90 (1.60) | .022* |
| PDW (%) | 15.80 (3.70) | 12.70 (2.40) | <.0001* |
| FIB (g/L) | 2.50 (0.79) | 2.47 (0.8) | .952 |
| PT (s) | 11.70 (0.80) | 11.60 (0.80) | .003* |
| PTINR | 1.02 (0.07) | 1.01 (0.07) | .003* |
| APTT (s) | 27.65 (3.70) | 28.10 (2.70) | .648 |
| TT (s) | 18.20 (1.10) | 18.30 (1.20) | .460 |
| DD2 (mg/L) | 0.22 (0.22) | 0.22 (0.22) | .361 |
| AFP (ng/ml) | 2.86 (1.62) | 2.82 (1.92) | .816 |
| CEA (U/ml) | 2.24 (1.78) | 2.11 (1.54) | .153 |
| CA199 (U/ml) | 9.22 (9.18) | 9.25 (8.72) | .828 |
| CYFRA211 (ng/ml) | 1.74 (0.93) | 1.89 (1.19) | .214 |
| NSE (ng/ml) | 16.88 (6.90) | 17.28 (7.58) | .161 |
Note: Abbreviations: EEC, Early Esophageal Cancer; WBC, White Blood Cell; MO, Monocyte; LY, Lymphocyte; NE, Neutrophils; PLT, platelet; NLR, Neutrophil-Lymphocyte Ratio; PLR, Platelet-Lymphocyte Ratio; MLR, Monocyte-to-Lymphocyte Ratio; EO, Eosinophils; BA, Basophils; RBC, Red Blood Cell; HGB, Hemoglobin; HCT, hematocrit; MCV, Mean Corpuscular Volume; MCH, Mean Corpuscular Hemoglobin; PDW, Platelet Distribution Width; MPV, Mean Platelet Volume; FIB, fibrin; PT, Prothrombin Time; INR, International Normalized Ratio; APTT, Activated Partial Thromboplastin Time; TT, Thrombin Time; DD2, D-dimer; AFP, Alpha-Fetoprotein; CEA, Carcinoembryonic Antigen; CA199, Cancer antigen 19-9; CYFRA211, cytokeratin 19 fragment; NSE, Neuron Specific Enolase.